| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Timothy Stover | VP, Corporate Controller | $137,981 | 30 Aug 2023 | ||
| Jerome B. Zeldis | Executive VP of Research & Dev | 05 Apr 2022 | |||
| Sol J. Barer | Director | 05 Jul 2023 | |||
| Zhengbin Yao | Director | 05 Jul 2023 | |||
| Timothy Bertram | Director | 05 Jul 2023 | |||
| John Trainer | Chief Financial Officer | 04 Apr 2023 | |||
| Grant Verstandig | Director | 05 Jul 2023 | |||
| Albert N. Marchio II | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney | 05 Apr 2024 | |||
| Robert Douglas Knight | Chief Medical Officer | 05 Apr 2022 | |||
| Leena Gandhi | Director | 05 Jul 2023 | |||
| Paul D'Angio | Director | 05 Jul 2023 | |||
| Kristi Jones | President and CEO, Director | 11 Jun 2024 | |||
| Alan S. Roemer | Director | 21 Nov 2023 | |||
| Mathias Oelke | Chief Science Officer | 04 Apr 2023 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||